Analyst consensus rating
Aurinia Pharmaceuticals Analyst Rating: none
Direct answer
Aurinia Pharmaceuticals's consensus rating is none.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.86.
Forecast evidence checked October 12, 2026.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.66
- Average price target
- $17.86
- High price target
- $21.00
- Low price target
- $16.00
- Low target gap
- -4%
- Target upside
- +7.2%
- High target gap
- +26.1%
- Target range width
- 30%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- October 12, 2026
- Valid through
- October 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $17.86.
How far are Aurinia Pharmaceuticals's low and high targets from the recorded price?
The low target implies -4%, while the high target implies +26.1%.
How many analysts are included in Aurinia Pharmaceuticals's consensus?
The verified consensus includes 7 analysts.
How is Aurinia Pharmaceuticals's target upside or downside calculated?
The average target of $17.86 is divided by the recorded price of $16.66, then one is subtracted to produce +7.2%. This does not guarantee a future return.
When was Aurinia Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-10-12. The dataset is valid through 2026-10-19.